anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
Enochian BioSciences · pitchdeck

Enochian Biosciences | Investor Presentation Deck | 39 slides

39 pages · 4 arc beats · 2 loops

Pitchdeck Download JSON
Unlock

Enochian Biosciences | Investor Presentation Deck | 39 slides

Enochian BioSciences · 2022-10
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 2
— No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.
—

Deck intelligence map

4
coverage by narrative range · generated from this deck JSON
Narrative range 8 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Problem 2 slides 100% 2/2 slides 100% 2/2 slides · 9 hits
— 0/2 slides
— 0/2 slides
50% 1/2 slides 100% 2/2 slides 100% 2/2 slides Solution 2 slides 100% 2/2 slides 100% 2/2 slides · 9 hits
— 0/2 slides
— 0/2 slides
50% 1/2 slides 100% 2/2 slides 100% 2/2 slides Market Size 1 slides 100% 1/1 slides 100% 1/1 slides · 3 hits
— 0/1 slides
— 0/1 slides
100% 1/1 slides 100% 1/1 slides
— 0/1 slides
Team 3 slides 100% 3/3 slides 100% 3/3 slides · 21 hits
— 0/3 slides
33.3% 1/3 slides
— 0/3 slides
100% 3/3 slides
— 0/3 slides

Slide inventory

39
every slide · same image gating as the playbook
01
Slide 1
front_matter
Open slide detail
02
other
Open slide detail
03
establish_context
Open slide detail
04
inspire_vision
Open slide detail
05
present_solution
Open slide detail
06
The slide uses a chevron-based table structure to link disease states to market validation.size_opportunity
Open slide detailBeat · Market Size
07
The diagram uses a branching logic to show how core pipelines lead to multiple indications/products, which then feed into a value-maximization arrow.present_solution
Open slide detail
08
The slide uses a Gantt-style visualization to show progress of drug candidates.plan_implementation
Open slide detail
09
other
Open slide detailBeat · Team
10
other
Open slide detailBeat · Team
11
other
Open slide detailBeat · Team
12
transition
Open slide detail
13
The slide uses a biological process diagram to illustrate the mechanism of immune cell activation.frame_problem
Open slide detailBeat · ProblemLoop · Cost Of Inaction
14
The slide uses a visual metaphor to explain immune evasion.frame_problem
Open slide detailBeat · ProblemLoop · Cost Of Inaction
15
The slide uses a visual metaphor of a dendritic cell connecting to a stacked list of therapeutic outcomes.present_solution
Open slide detailBeat · SolutionLoop · Cost Of Inaction
16
The slide uses a process flow framework to explain the production of an off-the-shelf cell therapy.present_solution
Open slide detailBeat · SolutionLoop · Cost Of Inaction
17
The slide presents visual evidence (photos of tumors) alongside quantitative bar charts showing efficacy metrics.show_traction
Open slide detailLoop · Cost Of Inaction
18
The slide uses a ribbon-style process diagram to show progression from proof-of-concept to clinical trials.plan_implementation
Open slide detailLoop · Cost Of Inaction
19
transition
Open slide detail
20
present_solution
Open slide detail
21
front_matter
Open slide detail
22
The slide uses a process flow diagram to explain the therapeutic mechanism.present_solution
Open slide detail
23
The slide uses a ribbon-style timeline visualization.plan_implementation
Open slide detail
24
transition
Open slide detail
25
The slide uses a list of key value propositions for the therapy.present_solution
Open slide detail
26
The chart shows a significant drop in viral load after day 14, maintaining a low level from day 145 onwards.show_traction
Open slide detail
27
plan_implementation
Open slide detail
28
transition
Open slide detail
29
Mentions a specific cost range ($300k-$450k) as a pain point for current CAR-T therapies.present_solution
Open slide detail
30
transition
Open slide detail
31
Uses a vertical process-style list with icons to denote key product attributes.present_solution
Open slide detail
32
The diagram uses a visual contrast between infected and uninfected cells to demonstrate specificity.present_solution
Open slide detail
33
The slide uses a ribbon-style process diagram to show sequential milestones.plan_implementation
Open slide detail
34
appendix
Open slide detail
35
The slide serves as a formal disclosure of the company's IP moat.cite_precedent
Open slide detail
36
transition
Open slide detailLoop · Why Now
37
The slide uses a process-oriented layout to categorize projects into 'Therapeutic Vaccine Platform' and 'Platform Expansion'.plan_implementation
Open slide detailLoop · Why Now
38
state_next_steps
Open slide detail
39
appendix
Open slide detail